Close Menu

The Daily Scan recently brought you the blogosphere's reaction to a new website called The Third Reviewer, which allows members of the scientific community to comment — anonymously, if they wish — on published scientific literature. DrugMonkey was among the bloggers who thought it was a great idea because anonymous commenting could allow researchers to be honest about the work of others without fearing they'd be attacked.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.